UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial
Titel:
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial
Auteur:
Haakensen, Vilde Drageset Öjlert, Åsa Kristina Thunold, Solfrid Farooqi, Saima Nowak, Anna K. Chin, Wee L. Grundberg, Oscar Szejniuk, Weronika Maria Cedres, Susana Sørensen, Jens Benn Dalen, Tonje Sofie Lund-Iversen, Marius Bjaanæs, Maria Helland, Åslaug